George Church
Harvard Medical School and Massachusetts Institute of Technology
George Church, PhD, is a professor of genetics at Harvard Medical School and of health sciences and technology at Harvard and the Massachusetts Institute of Technology. His work centers on genetics, gene editing technology, and synthetic biology, and he contributed to the Human Genome Project. His published research spans topics including genome editing design, DNA synthesis, spatial transcriptomics, synthetic cellular circuits, genetic recoding, and adult genomic sequencing.
53 claims checked on air: 3 context 3 overstated 38 supported 9 unverified
What they said on air - overstated
2 citing their own research
The speed and cost-efficiency of reading and writing DNA has improved exponentially by 10 to 30 million-fold over the last decade or two, doubling at least once a year and sometimes by a factor of 10 per year.
"How fast? It doubles at least once a year, sometimes we'll get a factor of 10 per year, as measured by both reading and writing DNA. Most of the 10, 20, 30 million-fold has occurred within the last decade or two." (said at 0:31:55)
While the throughput and cost-efficiency of DNA sequencing (reading DNA) improved by roughly 100,000-fold to several million-fold following the introduction of next-generation sequencing in the mid-2000s—temporarily outpacing Moore's law with annual 5- to 10-fold gains—DNA synthesis (writing DNA) has advanced at a substantially slower rate (typically several thousand-fold for standard gene synthesis rather than tens of millions-fold). Bundling both reading and writing together under a 10- to 30-million-fold improvement over the last two decades overstates the progress achieved in DNA synthesis.
Gene therapies using follistatin and telomerase reproducibly improve hallmarks, biomarkers, and diseases of aging across mouse models.
"experiments with follistatin and telomerase, so that affects the ends of the chromosomes, the telomeres. Follistatin is mostly muscle-aimed. But each of these has, you know, reproducible impact on hallmarks of aging, biomarkers of aging, and diseases of aging." (said at 1:01:56)
While telomerase (TERT) gene therapy has been shown in pre-clinical mouse models to improve select aging biomarkers and extend median lifespan (e.g., Bernardes de Jesus et al., 2012), claiming that follistatin and telomerase gene therapies have established, reproducible impacts across hallmarks, biomarkers, and diseases of aging overstates the current scientific evidence. A widely cited study reporting simultaneous lifespan extension and reversal of aging hallmarks using CMV-delivered telomerase and follistatin in mice (Dabke et al., PNAS 2022) was subsequently retracted due to concerns regarding data integrity. Outside of established animal work on follistatin for muscle mass and specific TERT gene therapy models, evidence across broader aging hallmarks remains preliminary, unverified in humans, and limited by non-reproducibility.
- partial: Telomerase gene therapy in adult and old mice delays aging and increases longevity without… (EMBO molecular medicine 2012) · cited 539x in the literature
"Treatment of 1- and 2-year old mice with an adeno associated virus (AAV) of wide tropism expressing mouse TERT had remarkable beneficial effects on health and fitness, including insulin sensitivity, osteoporosis, neuromuscular coordination and several molecular biomarkers of aging... Finally, telomerase-treated mice, both at 1-year and at 2-year of age, had an increase in median lifespan of 24 and 13%, respectively." (abstract, results, passage verified)
pubmedfull study (doi) - contradicts: New intranasal and injectable gene therapy for healthy life extension. (Proceedings of the National Academy of Sciences of the United States of America 2022)RETRACTED · cited 55x in the literature
"We found that the mouse cytomegalovirus (MCMV) carrying exogenous TERT or FST (MCMVTERT or MCMVFST) extended median lifespan by 41.4% and 32.5%, respectively." (abstract, results (Retracted Publication), passage verified)
pubmedfull study (doi)
Vitamin A deficiency causes approximately 1 million deaths per year worldwide.
"Golden rice is an example of something where vitamin A deficiency kills a million people a year" (said at 1:26:16)
While vitamin A deficiency (VAD) is a well-established cause of increased morbidity, visual impairment, and child mortality—and large trials demonstrate that supplementation significantly reduces all-cause child mortality—the claim that it causes 1 million deaths per year substantially overstates current global mortality figures. According to Global Burden of Disease (GBD 2021) data, annual global deaths attributable to VAD were estimated at approximately 188,500 in 1990 and have fallen to approximately 17,400 in 2021. The figure of 'one million' appears in older scientific literature either as a combined estimate of global deaths together with instances of blindness, or as a combined mortality figure across multiple micronutrient deficiencies (such as vitamin A and zinc combined).
- context: A global clinical view on vitamin A and carotenoids. (The American journal of clinical nutrition 2012) · cited 205x in the literature
"Deficiency, which is widespread throughout the developing world, is responsible for a million or more instances of unnecessary death and blindness each year." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Vitamin A supplementation for preventing morbidity and mortality in children from six mont… (The Cochrane database of systematic reviews 2022) · cited 73x in the literature
"Vitamin A deficiency (VAD) is a major public health problem in low- and middle-income countries, affecting 190 million children under five years of age and leading to many adverse health consequences, including death." (abstract, background, passage verified)
pubmedfull study (doi) - contradicts: Global, regional, and national burden of vitamin A deficiency (1990-2021) and projections … (Frontiers in nutrition 2025)
"Between 1990 and 2021, the global number of deaths attributable to VAD decreased from 188458.416 to 17374.404; the ASR declined from 3.04 to 0.27 per 100,000 population (EAPC: -7.81%)." (abstract, results, passage verified)
pubmedfull study (doi)
Fact-checked episodes
Publications
- Standardized metrics for assessment and reproducibility of imaging-based spatial transcriptomics datasets.Nature biotechnology 2026 · CEBM Level 5
- A Simple, Ultrastable, and Cost-Effective Oxygen-Scavenging System for Long-Term DNA-PAINT Imaging.Small (Weinheim an der Bergstrasse, Germany) 2026 · CEBM Level 5
- Nutrient requirements of organ-specific metastasis in breast cancer.Nature 2026 · CEBM Level 5
- Manufacturing-aware generative models enable petascale synthesis of designed DNA.Nature biotechnology 2026 · CEBM Level 5
- Synthetic circuits for cell ratio control.Nature 2026 · CEBM Level 5
- A platform to design and optimise fluorogenic scFvs for detection of interleukin 33.Chemical science 2026 · CEBM Level 5
- Designing genome editing experiments with EditABLE.Genome biology 2026 · CEBM Level 5
- Programmable Nucleic Acid Sensing in Human Cells Using Circularizable ssDNA.Nature communications 2026 · CEBM Level 5
- Architectural fragility of gene regulatory networks underlies hematopoietic stem cell aging.bioRxiv : the preprint server for biology 2026 · CEBM Level 4
- Probing the limits of genetic recoding using multi-omics-guided evolution.Nature communications 2026 · CEBM Level 5
- Derivation of elephant induced pluripotent stem cells.Nature methods 2026 · CEBM Level 5
- DNA Cut-Ligation Cyclization Surpasses Jacobson-Stockmayer J-Factor Expectations by over Threefold.Biomolecules 2026 · CEBM Level 5
- Elective genomic sequencing for adults in research, clinical and commercial contexts.medRxiv : the preprint server for health sciences 2026 · CEBM Level 4
- Elective genomic sequencing for adults in research, clinical and commercial contexts.BMC medical genomics 2026 · CEBM Level 4
- Erratum for Sengupta et al., "Antenna Modification in a Fast-Growing Cyanobacterium Synechococcus elongatus UTEX 2973 Leads to Improved Efficiency and Carbon-Neutral Productivity".Microbiology spectrum 2026 · CEBM Level 5
- Large-scale genome structure interrogation via recombinase-mediated rearrangements of multiplexed prime edits in repetitive elements.Nature protocols 2026 · CEBM Level 5
- On the ancestry and evolution of the extinct dire wolf.Cell genomics 2026 · CEBM Level 5
- Reply to: Overestimations in the cyclization efficiency of small, restriction enzyme-digested DNA fragments.Nature protocols 2026 · CEBM Level 5
- Transcriptome differences in lesions by color, and cancer mutations in endometriosis.Reproduction & fertility 2026 · CEBM Level 4
- Automated prototyping of genetic codes.Nature 2026 · CEBM Level 5
- Cryosectioning-enhanced super-resolution microscopy for single-protein imaging across cells and tissues.bioRxiv : the preprint server for biology 2025 · CEBM Level 5
- Template-independent enzymatic synthesis of RNA oligonucleotides.Nature biotechnology 2025 · CEBM Level 5
- Ovarian tumor cells gain competitive advantage by actively reducing the cellular fitness of microenvironment cells.Nature biotechnology 2025 · CEBM Level 5
- Novel Immune Response Evasion Strategy to Redose Adeno-associated Viral Vectors and Prolong Survival in Surfactant Protein-B-Deficient Mice.American journal of respiratory cell and molecular biology 2025 · CEBM Level 5
- PROTAR Vaccine 2.0 generates influenza vaccines by degrading multiple viral proteins.Nature chemical biology 2025 · CEBM Level 5
- Proteolysis-targeting influenza vaccine strains induce broad-spectrum immunity and in vivo protection.Nature microbiology 2025 · CEBM Level 5
- Rapid human oogonia-like cell specification via transcription factor-directed differentiation.EMBO reports 2025 · CEBM Level 5
- Randomizing the human genome by engineering recombination between repeat elements.Science (New York, N.Y.) 2025 · CEBM Level 5
- Circular Vectors as an efficient, fully synthetic, cell-free approach for preparing small circular DNA as a plasmid substitute for guide RNA expression in CRISPR-Cas9 genome editing.Nature protocols 2025 · CEBM Level 5
- Engineering gene drive docking sites in a haplolethal locus in Anopheles gambiae .bioRxiv : the preprint server for biology 2025 · CEBM Level 5
- High-Throughput Extracellular Vesicle Isolation Using Plate-Based Size Exclusion Chromatography and Automation.Journal of the American Chemical Society 2025 · CEBM Level 5
- A diverse single-stranded DNA-annealing protein library enables efficient genome editing across bacterial phyla.Proceedings of the National Academy of Sciences of the United States of America 2025 · CEBM Level 5
- A call for built-in biosecurity safeguards for generative AI tools.Nature biotechnology 2025 · CEBM Level 5
- Replacement as an aging intervention.Nature aging 2025 · CEBM Level 5
- DNA-PAINT Imaging with Hydrogel Imprinting and Clearing.ACS sensors 2025 · CEBM Level 5
- Machine-guided cell-fate engineering.Cell reports 2025 · CEBM Level 5
- Expansion in situ genome sequencing links nuclear abnormalities to aberrant chromatin regulation.Science (New York, N.Y.) 2025 · CEBM Level 5
- Iterative transcription factor screening enables rapid generation of microglia-like cells from human iPSC.Nature communications 2025 · CEBM Level 5
- Author Correction: PROTAR Vaccine 2.0 generates influenza vaccines by degrading multiple viral proteins.Nature chemical biology 2025 · CEBM Level 5
- Author Correction: Proteolysis-targeting influenza vaccine strains induce broad-spectrum immunity and in vivo protection.Nature microbiology 2025 · CEBM Level 5
- Aging on Chip: Harnessing the Potential of Microfluidic Technologies in Aging and Rejuvenation Research.Advanced healthcare materials 2025 · CEBM Level 5
- Medical digital twins: enabling precision medicine and medical artificial intelligence.The Lancet. Digital health 2025 · CEBM Level 5
- Skin health and biological aging.Nature aging 2025 · CEBM Level 5
- Biomaterials for organically generated habitats beyond Earth.Science advances 2025 · CEBM Level 5
- The Spatial Atlas of Human Anatomy (SAHA): A Multimodal Subcellular-Resolution Reference Across Human Organs.bioRxiv : the preprint server for biology 2025 · CEBM Level 4
- hafoe: an interactive tool for the analysis of chimeric AAV libraries after random mutagenesis.Gene therapy 2025 · CEBM Level 5
- Cryosectioning-enhanced super-resolution microscopy for single-protein imaging across cells and tissues.Proceedings of the National Academy of Sciences of the United States of America 2025 · CEBM Level 5
- A simple, ultrastable, and cost-effective oxygen-scavenging system for long-term DNA-PAINT imaging.bioRxiv : the preprint server for biology 2025 · CEBM Level 5
- Simulating a for-loop in the human genome: Design and evaluation of recombinase genetic programs that count to three.bioRxiv : the preprint server for biology 2025 · CEBM Level 5
- Initiation of meiosis from human iPSCs under defined conditions through identification of regulatory factors.Science advances 2025 · CEBM Level 5
- Validation of human sensory neurons derived from inducible pluripotent stem cells as a model for latent infection and reactivation by herpes simplex virus 1.mBio 2025 · CEBM Level 5
- Combinatorial protein barcodes enable self-correcting neuron tracing with nanoscale molecular context.bioRxiv : the preprint server for biology 2025 · CEBM Level 5
- Genetic signatures of exceptional longevity: a comprehensive analysis of coding region single nucleotide polymorphisms (SNPs) in centenarians and supercentenarians.Human genomics 2025 · CEBM Level 4
- Engineering gene drive docking sites in a haplolethal locus in Anopheles gambiae.Scientific reports 2025 · CEBM Level 5
- Large language models for drug discovery and development.Patterns (New York, N.Y.) 2025 · CEBM Level 5
- Integrated AAV optimization enables efficient gene delivery to kidney in murine and human tissue.Research square 2025 · CEBM Level 5
- Plasmid2MC: efficient cell-free generation of high-purity minicircle DNA for genome editing in mammalian cells.Communications biology 2025 · CEBM Level 5
- Engineered base editors with reduced bystander editing through directed evolution.Nature biotechnology 2025 · CEBM Level 5
- Progress and limitations in engineering cellular adhesion for research and therapeutics.Trends in cell biology 2024 · CEBM Level 5
- Impaired neural stress resistance and loss of REST in bipolar disorder.Molecular psychiatry 2024 · CEBM Level 4
- A second-generation M1-polarized CAR macrophage with antitumor efficacy.Nature immunology 2024 · CEBM Level 5
- Author Correction: A second-generation M1-polarized CAR macrophage with antitumor efficacy.Nature immunology 2024 · CEBM Level 5
- Highly cooperative chimeric super-SOX induces naive pluripotency across species.Cell stem cell 2024 · CEBM Level 5
- Protein design meets biosecurity.Science (New York, N.Y.) 2024 · CEBM Level 5
- Rapid Generation of hPSC-Derived High Endothelial Venule Organoids with In Vivo Ectopic Lymphoid Tissue Capabilities.Advanced materials (Deerfield Beach, Fla.) 2024 · CEBM Level 5
- Genome streamlining to improve performance of a fast-growing cyanobacterium Synechococcus elongatus UTEX 2973.mBio 2024 · CEBM Level 5
- CRISPR-mediated germline mutagenesis for genetic sterilization of Anopheles gambiae males.Scientific reports 2024 · CEBM Level 5
- Comprehensive mutagenesis maps the effect of all single-codon mutations in the AAV2 rep gene on AAV production.eLife 2024 · CEBM Level 5
- Sendai virus persistence questions the transient naive reprogramming method for iPSC generation.bioRxiv : the preprint server for biology 2024 · CEBM Level 5
- Testing multiplexed anti-ASFV CRISPR-Cas9 in reducing African swine fever virus.Microbiology spectrum 2024 · CEBM Level 5
- Assessing contemporary Arctic habitat availability for a woolly mammoth proxy.Scientific reports 2024 · CEBM Level 5
- Uncovering the dynamics and consequences of RNA isoform changes during neuronal differentiation.Molecular systems biology 2024 · CEBM Level 5
- Post-translational digital data encoding into the genomes of mammalian cell populations.bioRxiv : the preprint server for biology 2024 · CEBM Level 5
- Induction of Meiosis from Human Pluripotent Stem Cells.bioRxiv : the preprint server for biology 2024 · CEBM Level 5
- A second space age spanning omics, platforms and medicine across orbits.Nature 2024 · CEBM Level 5
- The Space Omics and Medical Atlas (SOMA) and international astronaut biobank.Nature 2024 · CEBM Level 4
- Spatial multi-omics of human skin reveals KRAS and inflammatory responses to spaceflight.Nature communications 2024 · CEBM Level 4
- Longitudinal multi-omics analysis of host microbiome architecture and immune responses during short-term spaceflight.Nature microbiology 2024 · CEBM Level 4
- Synthetic genomes unveil the effects of synonymous recoding.bioRxiv : the preprint server for biology 2024 · CEBM Level 5
- Multiplexed in situ protein imaging using DNA-barcoded antibodies with extended hybridization chain reactions.Nucleic acids research 2024 · CEBM Level 5
- Protective alleles and precision healthcare in crewed spaceflight.Nature communications 2024 · CEBM Level 5
- Comparative transcriptome analysis of acne vulgaris, rosacea, and hidradenitis suppurativa supports high-dose dietary zinc as a therapeutic agent.Experimental dermatology 2024 · CEBM Level 5
- EditABLE: A Simple Web Application for Designing Genome Editing Experiments.Research square 2024 · CEBM Level 5
- Algorithms for Autonomous Formation of Multicellular Shapes from Single Cells.ACS synthetic biology 2024 · CEBM Level 5
- Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer.Cancer cell 2024 · CEBM Level 3
- Rapid discovery and evolution of nanosensors containing fluorogenic amino acids.Nature communications 2024 · CEBM Level 5
- The 1% gift to humanity: The Human Genome Project II.Cell research 2024 · CEBM Level 5
- SeqVerify: An accessible analysis tool for cell line genomic integrity, contamination, and gene editing outcomes.Stem cell reports 2024 · CEBM Level 5
- Defining an Ageing-Related Pathology, Disease or Syndrome: International Consensus Statement.medRxiv : the preprint server for health sciences 2024 · CEBM Level 5
- Structural brain preservation: a potential bridge to future medical technologies.Frontiers in medical technology 2024 · CEBM Level 5
- Towards geospatially-resolved public-health surveillance via wastewater sequencing.Nature communications 2024 · CEBM Level 3
- Expansion in situ genome sequencing links nuclear abnormalities to hotspots of aberrant euchromatin repression.bioRxiv : the preprint server for biology 2024 · CEBM Level 5
- Cyanobacteria newly isolated from marine volcanic seeps display rapid sinking and robust, high-density growth.Applied and environmental microbiology 2024 · CEBM Level 5
- Measurement of α-synuclein as protein cargo in plasma extracellular vesicles.Proceedings of the National Academy of Sciences of the United States of America 2024 · CEBM Level 4
- Temporal recording of mammalian development and precancer.Nature 2024 · CEBM Level 5
- Confronting risks of mirror life.Science (New York, N.Y.) 2024 · CEBM Level 5
- Herpes Simplex Virus 1 Infection of Human Brain Organoids and Pancreatic Stem Cell-Islets Drives Organoid-Specific Transcripts Associated with Alzheimer's Disease and Autoimmune Diseases.Cells 2024 · CEBM Level 5
- A swapped genetic code prevents viral infections and gene transfer.Nature 2023 · CEBM Level 5
- PAM-Flexible Genome Editing with an Engineered Chimeric Cas9.Research square 2023 · CEBM Level 5
- Correction: Directed differentiation of human iPSCs to functional ovarian granulosa-like cells via transcription factor overexpression.eLife 2023 · CEBM Level 5
- Centenarian clocks: epigenetic clocks for validating claims of exceptional longevity.GeroScience 2023 · CEBM Level 3
- Transcriptomic reprogramming for neuronal age reversal.Human genetics 2023 · CEBM Level 5
- Mitigating age-related somatic mutation burden.Trends in molecular medicine 2023 · CEBM Level 5
- Improved isolation of extracellular vesicles by removal of both free proteins and lipoproteins.eLife 2023 · CEBM Level 5
- Antenna Modification in a Fast-Growing Cyanobacterium Synechococcus elongatus UTEX 2973 Leads to Improved Efficiency and Carbon-Neutral Productivity.Microbiology spectrum 2023 · CEBM Level 5
- Modeling of mitochondrial genetic polymorphisms reveals induction of heteroplasmy by pleiotropic disease locus 10398A>G.Scientific reports 2023 · CEBM Level 3
- Geospatially-resolved public-health surveillance via wastewater sequencing.medRxiv : the preprint server for health sciences 2023 · CEBM Level 4
- CRISPR-mediated germline mutagenesis for genetic sterilization of Anopheles gambiae males.bioRxiv : the preprint server for biology 2023 · CEBM Level 5
- Fertility restoration in mice with chemotherapy induced ovarian failure using differentiated iPSCs.EBioMedicine 2023 · CEBM Level 5
- Strategies to identify and edit improvements in synthetic genome segments episomally.Nucleic acids research 2023 · CEBM Level 5
- Reliable multiplex generation of pooled induced pluripotent stem cells.Cell reports methods 2023 · CEBM Level 5
- PAM-flexible genome editing with an engineered chimeric Cas9.Nature communications 2023 · CEBM Level 5
- Design and testing of a humanized porcine donor for xenotransplantation.Nature 2023 · CEBM Level 5
- SeqVerify: An accessible analysis tool for cell line genomic integrity, contamination, and gene editing outcomes.bioRxiv : the preprint server for biology 2023 · CEBM Level 5
- Engineering Ca 2+ -Dependent DNA Polymerase Activity.ACS synthetic biology 2023 · CEBM Level 5
- Viral activation and ecological restructuring characterize a microbiome axis of spaceflight-associated immune activation.Research square 2023 · CEBM Level 3
- Comparative Transcriptome Analysis of Acne vulgaris, Rosacea, and Hidradenitis Suppurativa Supports High Dose Dietary Zinc as a Therapeutic Agent.medRxiv : the preprint server for health sciences 2023 · CEBM Level 5
- Temporal recording of mammalian development and precancer.bioRxiv : the preprint server for biology 2023 · CEBM Level 4